Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time.

about

Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer's disease.Neuroinflammation and Tau Interact with Amyloid in Predicting Sleep Problems in Aging Independently of Atrophy.Orexin and Alzheimer's Disease.

P2860

Q47686147-AA7013DE-95B0-46FF-A7A2-80C2B62B981B Q47715715-23F0C53B-67FB-4E23-9629-24B4E8BD1E09 Q47780791-B57F36DB-8C77-4CDE-97E3-4345C85915F4

P2860

Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time.

Item

http://www.wikidata.org/entity/Q47895702

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time.

@en

Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time.

@nl

type

Item

label

Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time.

@en

Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time.

@nl

prefLabel

Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time.

@en

Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time.

@nl

P1476

Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time.

@en

P2093

Andrea Romigi

http://www.w3.org/2001/XMLSchema#string

Claudio Liguori

http://www.w3.org/2001/XMLSchema#string

Fabio Placidi

http://www.w3.org/2001/XMLSchema#string

Fabrizio Cum

http://www.w3.org/2001/XMLSchema#string

Francesca Izzi

http://www.w3.org/2001/XMLSchema#string

Maria Giovanna Sarpa

http://www.w3.org/2001/XMLSchema#string

Maria Grazia Marciani

http://www.w3.org/2001/XMLSchema#string

Marzia Nuccetelli

http://www.w3.org/2001/XMLSchema#string

Sergio Bernardini

http://www.w3.org/2001/XMLSchema#string

P2860

The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide

Effects of oral L-carnitine administration in narcolepsy patients: a randomized, double-blind, cross-over and placebo-controlled trial

Abnormally low serum acylcarnitine levels in narcolepsy patients

Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination.

Hypocretin and brain β-amyloid peptide interactions in cognitive disorders and narcolepsy.

The secretases: enzymes with therapeutic potential in Alzheimer disease.

Reduced number of hypocretin neurons in human narcolepsy.

The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.

Clinical aspects and pathophysiology of narcolepsy.

Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives.

P2888

s11325-015-1305-9

P304

277-83; discussion 283

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11325-015-1305-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nicola B. Mercuri

Maria Grazia Marciani

P577

2016-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26803606

http://www.w3.org/2001/XMLSchema#string

P921

narcolepsy

phosphorylation

Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time.

about

P2860

P2860

Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921